Gabapentin is an anticonvulsant medication primarily approved to treat seizures and nerve pain, but some healthcare providers may prescribe it off-label for certain mental health conditions. While research on gabapentin for depression remains limited, understanding what the existing evidence shows can help you make informed decisions about your treatment options.
Gabapentin is not FDA-approved for treating depression, and current research does not support its use as a primary depression treatment.
However, it may still be helpful as an add-on treatment in certain cases, especially for people with depression that hasn’t improved with other treatments and who also have anxiety or some types of nerve pain.
Key Takeaways
Gabapentin is not FDA-approved for depression and lacks strong research evidence supporting its effectiveness as a primary treatment for major depressive disorder.
Some studies suggest gabapentin may help as an add-on treatment for people with treatment-resistant depression, particularly those with prominent anxiety symptoms or certain bipolar features.
Evidence-based treatments like selective serotonin reuptake inhibitors (SSRIs), serotonin–noradrenaline reuptake inhibitors (SNRIs), and psychotherapy remain the first-line options for depression, with significantly more research supporting their effectiveness and safety.
What Is Gabapentin?
Gabapentin belongs to a class of medications called anticonvulsants. The FDA approved it in 1993 for preventing seizures and managing nerve pain conditions like postherpetic neuralgia. The medication works by affecting calcium channels in the nervous system, though researchers don't fully understand all of its mechanisms.
Despite its FDA-approved uses, healthcare providers sometimes prescribe gabapentin off-label for various conditions, including:
Anxiety disorders
Alcohol use disorder
Mood disorders
Chronic pain conditions
Sleep disturbances
Off-label prescribing means using a medication for purposes not specifically approved by the FDA, which is legal and sometimes appropriate when supported by clinical experience or research evidence.
Research on Gabapentin for Depression
The scientific evidence for using gabapentin to treat depression is limited and mixed, with most studies showing it's not effective as a standalone treatment.
Limited Evidence for Major Depressive Disorder
A systematic review examining gabapentin in psychiatric disorders found no clear evidence supporting gabapentin therapy for depression. The review concluded that while gabapentin appears effective for certain anxiety disorders and alcohol dependence, it lacks convincing evidence for treating major depressive disorder, post-traumatic stress disorder (PTSD), or obsessive-compulsive disorder (OCD).
Research notes that there are no randomized controlled trials assessing gabapentin's efficacy for major depressive disorder. This absence of high-quality research makes it difficult to recommend gabapentin as a depression treatment based on current evidence.
Potential Benefits as an Add-On Treatment
Some research suggests gabapentin might help certain individuals when added to existing antidepressant therapy. A study examined 27 patients with treatment-resistant depression who received gabapentin as an add-on treatment. The study found that clinician-rated measures improved significantly over 15 weeks, with patients taking a mean final dose of 904 mg per day.
In this study, patients who benefited the most commonly had prominent anxiety symptoms or certain bipolar features. However, the study was small and had no control group, so it’s unclear whether gabapentin actually caused the improvements.
How Gabapentin Differs from Proven Depression Treatments
Unlike medications specifically approved for depression, gabapentin lacks the robust research foundation that supports first-line treatments.
SSRIs and SNRIs have decades of research demonstrating their effectiveness for depression. These medications target neurotransmitter systems known to be involved in mood regulation, and their benefits have been proven across multiple large, well-designed clinical trials.
Healthcare providers might consider adding gabapentin to a treatment plan in specific situations. If you have depression that hasn't responded to multiple standard treatments and you also experience significant anxiety, chronic pain conditions, or certain sleep disturbances, your psychiatrist might discuss whether gabapentin could be worth trying as an add-on therapy.
Potential Risks and Side Effects
Like all medications, gabapentin carries potential risks that should be carefully weighed against possible benefits.
Common Side Effects
People taking gabapentin commonly experience several side effects that can overlap with depression symptoms. These include:
Fatigue and sedation
Dizziness
Gastrointestinal symptoms (nausea, upset stomach)
Drowsiness
Difficulty concentrating
These side effects can make it difficult to assess whether the medication is helping or worsening your condition. The drowsiness that gabapentin causes might be particularly problematic for people with depression who already struggle with fatigue and low energy.
Abuse and Dependence Concerns
Research indicates that gabapentin has potential for abuse, especially in people with a history of substance use disorders.
While gabapentin isn't classified as a controlled substance in most states, misuse patterns have emerged, particularly among individuals with opioid or alcohol use disorders. If you have a history of substance use concerns, this is an important factor to discuss with your healthcare provider.
Interactions and Precautions
Gabapentin can interact with other medications and substances.
Combining it with alcohol or other central nervous system depressants can increase sedation and impair coordination. If you're taking multiple medications, your healthcare provider needs to carefully review potential interactions before adding gabapentin to your regimen.
Evidence-based Alternatives for Depression Treatment
Several treatment options have much stronger evidence supporting their use for depression than gabapentin.
First-line Medications
Antidepressants remain the most thoroughly researched medication option for depression. Proven effective medications include:
SSRIs: Escitalopram, sertraline, fluoxetine
SNRIs: Venlafaxine, duloxetine
Atypical antidepressants: Bupropion, mirtazapine
These medications typically take four to eight weeks to show their full benefits. For people who don't respond to initial antidepressant treatment, psychiatrists can try different medications, adjust dosages, or combine treatments. Studies show that many people who don't respond to their first antidepressant do find relief with alternative medications or combinations.
Psychotherapy
Talk therapy, particularly cognitive-behavioral therapy, has extensive research supporting its effectiveness for depression.
Therapy can be used alone for mild to moderate depression or combined with medication for more severe cases. Unlike medication, therapy teaches skills that keep helping you even after treatment ends.
Advanced Treatment Options
For treatment-resistant depression, several evidence-based options exist beyond trying gabapentin:
Transcranial Magnetic Stimulation (TMS): Non-invasive brain stimulation therapy
Electroconvulsive Therapy (ECT): Highly effective for severe, treatment-resistant depression
Esketamine (Spravato): FDA-approved nasal spray for treatment-resistant depression
Combination therapy: Using multiple medications or approaches together
Your psychiatrist can discuss whether any of these options might be appropriate for your situation.
Making an Informed Decision
When considering any treatment for depression, especially one used off-label like gabapentin, weigh the quality of evidence, potential benefits, risks, and the alternatives to make an informed decision.
Current research doesn't support gabapentin as a first-line treatment for depression. While some individuals might benefit from it as an add-on therapy in specific circumstances, many people would likely find better results with treatments that have stronger evidence behind them.
If you're struggling with treatment-resistant depression, working with a psychiatrist who specializes in complex cases can help ensure you're exploring all appropriate evidence-based options.
Depression is highly treatable, and the vast majority of people find relief with proper treatment. If your current approach isn't working, that doesn't mean you're out of options—it means you may need a different medication, a different therapy approach, or a combination of treatments tailored to your specific needs.
Managing Care for Depression
If depression is affecting your mood, relationships, or daily life, professional support can help you better understand your symptoms and find effective ways to feel better. Virtual mental health care makes it easier than ever to connect with experienced providers from the comfort of home.
At Blossom Health, we connect you with board-certified psychiatrists who specialize in treating depression and related challenges.
Our providers work with you to identify underlying factors, explore evidence-based treatment options, and support lasting emotional well-being—often covered by your in-network insurance. Visit Blossom Health to schedule your first appointment and take the first step toward relief and renewed balance.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Sources
Yasaei R, Katta S, Patel P, et al. Gabapentin. 2025. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK493228/
Martin JC, Gainer D. 2022. Psychiatric Uses of Gabapentin. Innov Clin Neurosci.https://pmc.ncbi.nlm.nih.gov/articles/PMC6982454/
Berlin RK, Butler PM, Perloff MD. 2015. Gabapentin Therapy in Psychiatric Disorders: A Systematic Review. Prim Care Companion CNS Disord. https://pmc.ncbi.nlm.nih.gov/articles/PMC4732322/
Yasmin S, Carpenter LL, Leon Z, Siniscalchi JM, Price LH. 2001. Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review. J Affect Disord. https://pubmed.ncbi.nlm.nih.gov/11246103/
Ahmed S, Bachu R, Kotapati P, Adnan M, Ahmed R, Farooq U, Saeed H, Khan AM, Zubair A, Qamar I, Begum G. 2-19. Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review. Front Psychiatry. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2019.00228/full
Hong JSW, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A. 2022. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Mol Psychiatry.https://pmc.ncbi.nlm.nih.gov/articles/PMC9095464/
National Institute of Mental Health. Mental Health Medications. https://www.nimh.nih.gov/health/topics/mental-health-medications
American Psychiatric Association. What is Psychiatry?. https://www.psychiatry.org/patients-families/what-is-psychiatry
